People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Pharma, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Digital Therapeutics, Inc. | — | Pharma | Series C | $123.6M | $531.0M | 2021 |
| Permutive, Inc. | — | Other | Series C | $95.5M | $1.2B | 2018 |
| Inflow Holdings, Inc. | — | Other Technology | Series A | $13.6M | $168.6M | 2022 |
Will Gibbs at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Will Gibbs on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ben Blume | 1 | 6 |
| Alastair Mitchell | 1 | 3 |
| Christian Scherrer | 1 | 2 |
| Gabriel Mecklenburg | 1 | 2 |
| Sarim Siddiqui | 1 | 1 |
| Maroof Ahmed | 1 | 1 |
| Sebastian Isaacs | 1 | 1 |
| Levi Epstein | 1 | 1 |
| Timothy Spratt | 1 | 1 |
| Max Ohrstrand | 1 | 1 |
| Joseph Root | 1 | 1 |
| Yusuf Sherwani | 1 | 1 |
| Maria Maras | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.